• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜黑色素瘤的细胞遗传学:7年临床经验

Cytogenetics of uveal melanoma: a 7-year clinical experience.

作者信息

Damato Bertil, Duke Catherine, Coupland Sarah E, Hiscott Paul, Smith Peter A, Campbell Ian, Douglas Angela, Howard Peter

机构信息

Ocular Oncology Service, Royal Liverpool University Hospital, Liverpool, United Kingdom.

出版信息

Ophthalmology. 2007 Oct;114(10):1925-31. doi: 10.1016/j.ophtha.2007.06.012. Epub 2007 Aug 27.

DOI:10.1016/j.ophtha.2007.06.012
PMID:17719643
Abstract

PURPOSE

Chromosome 3 loss and chromosome 8 gains in uveal melanoma are associated with metastatic death. Since 1999, we have offered cytogenetic analysis to patients treated by local resection or enucleation. This study correlated our cytogenetic results with clinical and histologic predictors and disease-specific mortality.

DESIGN

Nonrandomized case series.

PARTICIPANTS

Three hundred fifty-six patients with uveal melanoma with data on chromosome 3 and chromosome 8.

METHODS

Tumor diameter was measured by echography. Cell type, presence of closed connective tissue loops, and mitotic rate were determined histopathologically. Fluorescence in-situ hybridization was performed using centromeric probes for chromosomes 3 and 8 and for c-myc. Patients were flagged at the National Health Service Cancer Registry, which notified us of any deaths. Statistics included Cox multivariate analysis and Kaplan-Meier analysis.

MAIN OUTCOME MEASURES

Disease-specific mortality, according to clinical, histologic and cytogenetic features as well as correlation between cytogenetic variables and other mortality predictors, including a predictive index.

RESULTS

The patients had a mean age of 61.9 years. The tumors showed no cytogenetic abnormalities of chromosomes 3 or 8 in 42%, chromosome 8 gains in 11%, monosomy 3 in 21%, and both abnormalities in 27%. These correlated with ciliary body involvement (P<0.001), extraocular spread (P = 0.007), large basal tumor diameter (P<0.001), epithelioid cellularity (P<0.001), closed connective tissue loops (P<0.001), and mitotic rate exceeding 4/40 high power fields (P<0.001). By the study close, 76 patients had died (67 from metastasis). Cox multivariate analysis showed the most significant factors to be basal tumor diameter (P<0.001), monosomy 3 (P<0.001), and epithelioid cellularity (P = 0.004). A predictive index (PI) was derived from these variables. Kaplan-Meier analysis showed that 5-year metastatic death rates ranged from 0% in 84 patients with low-grade melanoma (PI<19) to 66% in 100 patients with high-grade tumor (PI>26; 95% confidence interval, 53%-80%).

CONCLUSION

Cytogenetic analysis of chromosomes 3 and 8 enhances prediction of disease-specific mortality after treatment of uveal melanoma but must be interpreted together with tumor diameter and cell type.

摘要

目的

葡萄膜黑色素瘤中3号染色体缺失和8号染色体增加与转移性死亡相关。自1999年以来,我们为接受局部切除或眼球摘除术治疗的患者提供细胞遗传学分析。本研究将我们的细胞遗传学结果与临床、组织学预测指标及疾病特异性死亡率进行关联。

设计

非随机病例系列。

参与者

356例有3号和8号染色体数据的葡萄膜黑色素瘤患者。

方法

通过超声检查测量肿瘤直径。组织病理学确定细胞类型、闭合结缔组织环的存在情况及有丝分裂率。使用针对3号和8号染色体以及c-myc的着丝粒探针进行荧光原位杂交。患者在国家医疗服务体系癌症登记处进行标记,登记处会通知我们任何死亡情况。统计分析包括Cox多变量分析和Kaplan-Meier分析。

主要观察指标

根据临床、组织学和细胞遗传学特征的疾病特异性死亡率,以及细胞遗传学变量与其他死亡率预测指标之间的相关性,包括一个预测指数。

结果

患者的平均年龄为61.9岁。42%的肿瘤未显示3号或8号染色体的细胞遗传学异常,11%有8号染色体增加,21%有3号染色体单体性,27%有两种异常。这些与睫状体受累(P<0.001)、眼外扩散(P = 0.007)、基底肿瘤直径大(P<0.001)、上皮样细胞性(P<0.001)、闭合结缔组织环(P<0.001)以及有丝分裂率超过4/40高倍视野(P<0.001)相关。到研究结束时,76例患者死亡(67例死于转移)。Cox多变量分析显示最显著的因素是基底肿瘤直径(P<0.001)、3号染色体单体性(P<0.001)和上皮样细胞性(P = 0.004)。从这些变量得出一个预测指数(PI)。Kaplan-Meier分析显示,5年转移性死亡率在84例低级别黑色素瘤患者(PI<19)中为0%,在100例高级别肿瘤患者(PI>26;95%置信区间,53%-80%)中为66%。

结论

对3号和8号染色体进行细胞遗传学分析可增强葡萄膜黑色素瘤治疗后疾病特异性死亡率的预测,但必须结合肿瘤直径和细胞类型进行解读。

相似文献

1
Cytogenetics of uveal melanoma: a 7-year clinical experience.葡萄膜黑色素瘤的细胞遗传学:7年临床经验
Ophthalmology. 2007 Oct;114(10):1925-31. doi: 10.1016/j.ophtha.2007.06.012. Epub 2007 Aug 27.
2
Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.葡萄膜黑色素瘤眼外扩展途径:危险因素及对生存概率的影响
Ophthalmology. 2008 Oct;115(10):1778-85. doi: 10.1016/j.ophtha.2008.04.025. Epub 2008 Jun 13.
3
Clinical and cytogenetic analyses in uveal melanoma.葡萄膜黑色素瘤的临床与细胞遗传学分析
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3703-7. doi: 10.1167/iovs.06-0101.
4
Artificial neural networks estimating survival probability after treatment of choroidal melanoma.人工神经网络估计脉络膜黑色素瘤治疗后的生存概率。
Ophthalmology. 2008 Sep;115(9):1598-607. doi: 10.1016/j.ophtha.2008.01.032. Epub 2008 Mar 14.
5
Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.在葡萄膜黑素瘤细胞中,更高比例的 FISH 确定的单体 3 和 8q 扩增与患者预后不良有关。
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697.
6
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.3号染色体单体性与炎症表型在葡萄膜黑色素瘤中共同出现。
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10. doi: 10.1167/iovs.07-0786.
7
Cytogenetics and prognosis for uveal melanoma in Korean patients.韩国患者葡萄膜黑色素瘤的细胞遗传学与预后。
Acta Ophthalmol. 2011 Jun;89(4):e310-4. doi: 10.1111/j.1755-3768.2010.02099.x. Epub 2011 Feb 11.
8
Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.基于3号染色体状态的敷贴放疗和热疗后葡萄膜黑色素瘤的消退情况
Retina. 2008 Oct;28(9):1289-95. doi: 10.1097/IAE.0b013e31817f7b3e.
9
Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.碘近距离放射治疗作为大型葡萄膜黑色素瘤眼球摘除术的替代方法。
Ophthalmology. 2003 Nov;110(11):2223-34. doi: 10.1016/S0161-6420(03)00661-4.
10
Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.通过荧光原位杂交检测葡萄膜黑色素瘤中的c-myc扩增
Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1679-84.

引用本文的文献

1
Prognostic Biopsy of Choroidal Melanoma Before and After Ruthenium-106 Plaque Brachytherapy: Impact on Success of Cytogenetic Analysis.钌-106 敷贴近距离放疗前后脉络膜黑色素瘤的预后活检:对细胞遗传学分析成功率的影响
Cancers (Basel). 2025 Jun 19;17(12):2057. doi: 10.3390/cancers17122057.
2
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam Radiation.接受专用粒子束放疗的青少年和青年葡萄膜黑色素瘤患者的长期临床结局
Cancers (Basel). 2025 Jun 19;17(12):2042. doi: 10.3390/cancers17122042.
3
BAP1 Loss on Immunocytochemistry and Its Association With Monosomy 3 in Uveal Melanoma Fine-Needle Aspirations.
葡萄膜黑色素瘤细针穿刺物中免疫细胞化学检测BAP1缺失及其与3号染色体单体性的关联
Diagn Cytopathol. 2025 Jun 17. doi: 10.1002/dc.25496.
4
Plaque Radiotherapy for Ocular Melanoma.眼部黑色素瘤的斑块放射治疗
Cancers (Basel). 2024 Oct 3;16(19):3386. doi: 10.3390/cancers16193386.
5
Predicting Choroidal Nevus Transformation to Melanoma Using Machine Learning.使用机器学习预测脉络膜痣向黑色素瘤的转变。
Ophthalmol Sci. 2024 Jul 20;5(1):100584. doi: 10.1016/j.xops.2024.100584. eCollection 2025 Jan-Feb.
6
Correlation Analysis of Apparent Diffusion Coefficient Histogram Parameters and Clinicopathologic Features for Prognosis Prediction in Uveal Melanoma.浅析 ADC 直方图参数与葡萄膜黑色素瘤临床病理特征的相关性及其对预后的预测价值
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):3. doi: 10.1167/iovs.65.8.3.
7
Iodine Plaque Brachytherapy a Customized Conservative Approach to the Management of Medium/Large-sized Uveal Melanoma.碘斑近距离放射治疗:中/大型葡萄膜黑色素瘤的一种定制化保守治疗方法。
In Vivo. 2024 Jul-Aug;38(4):1814-1822. doi: 10.21873/invivo.13633.
8
Pathological and Molecular Diagnosis of Uveal Melanoma.葡萄膜黑色素瘤的病理与分子诊断
Diagnostics (Basel). 2024 May 2;14(9):958. doi: 10.3390/diagnostics14090958.
9
A Systematic Review and Meta-Analysis on the Diagnostic and Prognostic Values of F-FDG PET in Uveal Melanoma and Its Hepatic Metastasis.一项关于¹⁸F-FDG PET在葡萄膜黑色素瘤及其肝转移中的诊断和预后价值的系统评价与荟萃分析
Cancers (Basel). 2024 Apr 28;16(9):1712. doi: 10.3390/cancers16091712.
10
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline.葡萄膜黑色素瘤的管理:艾伯塔省癌症护理更新临床实践指南。
Curr Oncol. 2023 Dec 20;31(1):24-41. doi: 10.3390/curroncol31010002.